Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure Academic Article Article uri icon

Overview

MeSH Major

  • Anti-Infective Agents
  • Neoplasms
  • Sepsis

abstract

  • The use of phosphodiesterase inhibitors such as milrinone in the treatment of severe heart failure is frequently restricted because they cause vasodilation and hypotension. In patients with decompensated heart failure with hypotension after treatment with milrinone, low doses of vasopressin restored blood pressure without inhibiting the inotropic effect of milrinone.

publication date

  • February 15, 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0002-9149(99)00783-3

PubMed ID

  • 10728962

Additional Document Info

start page

  • 506

end page

  • 8, A11

volume

  • 85

number

  • 4